Escolar Documentos
Profissional Documentos
Cultura Documentos
Microbiology
N e w s l e t
CMN
Stay Current...
Stay Informed.
t e r
Infectious Meningitis
CMN
Issu e
43 Infectious Meningitis
AbdelRahman M. Zueter, M.L.S., M.Sc., Ph.D.,1 and Amani Zaiter, M.Sc.,2 1Department of Medical
Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia,
2
Biological Sciences Department, Faculty of Science, Hashemite University, Zarqa, Jordan
Abstract
Infectious meningitis is a large public health concern, especially in children and immunocompromised
patients. Although the epidemiology of meningitis has shown significant decline in past decades, partly
due to the introduction of vaccines, outbreaks are still reported worldwide. Diagnosis of meningitis is
of critical importance, and it is considered to be one of the most urgent of the microbiological medical emergencies. In order to improve the treatment strategy, various diagnostic methods have been
developed to detect the presence of infectious agents that cause meningitis, as well as their antibiotic
resistance patterns. This article aims to enhance the understanding of meningitis and to highlight the
most current updates that describe outbreaks of meningitis and the subsequent investigations. We also
describe the current diagnosis and treatment options.
Introduction
Corresponding author:
AbdelRahman M. Zueter,
M.L.S., M.Sc., Ph.D., Department of Medical Microbiology
and Parasitology, School of
Medical Sciences, Universiti
Sains Malaysia, 16150 Kubang
Kerian, Kelantan, Malaysia.
Tel.: 0060136709343. Fax:
0060197676289. E-mail:
zueterabdelrahman@gmail.com
Infectious Meningitis
Infectious meningitis is a serious disease of the
CNS that involves inflammation of the meninges
as a result of microbial infection, and it occurs in
all age groups. It is caused most commonly by
viruses and bacteria, rarely by fungi and parasites (9). The clinical presentation of meningitis
depends on the virulence of the causative agent,
the pathogenesis of spread to the CNS, and the
area of CNS involvement (3). Headache, fever,
stiff neck, confusion, vomiting, and pleocytosis
are features of meningeal inflammation and are
common to many types of meningitis (e.g., bacterial, fungal, viral, and chemical) and also to some
parameningeal processes. The CSF laboratory
findings are most helpful in distinguishing among
these processes (2).
43
The age of the host and other underlying host factors (head
trauma, neurosurgery, or presence of a CSF shunt) contribute to
the etiology and the routes of entry. Initially, infectious agents
colonize or establish localized infection in the skin, nasopharynx,
respiratory tract, gastrointestinal tract, or genitourinary tract of
the host. From these sites, the organisms invades by circumventing host defenses (e.g., physical barriers, local immunity, and
phagocytes/macrophages) and gains access to the CNS through
(i) hematogenous spread, the most common route of infection, in
which the organisms spread via the blood vessels of the brain to
enter the subarachanoid space; (ii) direct spread from an infected
neighboring site contiguous to the CNS; (iii) an anatomical defect
in the CNS structure that resulted from surgery, trauma, or congenital abnormalities, which can allow microorganisms to easily
access the CNS; or (iv) travel along nerves leading to the brain, as
occurs with some viruses. Of note, neonates have the highest risk
of infection because of their immature immune system and the
increased permeability of the blood brain barrier (10). Infectious
meningitis is grouped on the basis of pathogen type (bacterial,
viral, fungal, or parasitic), host age (neonate, pediatric, and adult),
health status (healthy or immunocompromised), and symptom
duration (acute, subacute, or chronic [recurrent]).
Meningitis is transmitted from person to person through respiratory secretions (saliva, sputum, or nasal mucus), through the fecaloral route, or vertically through the colonized vaginal canal. The
infection is considered to be acute during the period when signs
and symptoms of less than 24 hours duration are observed and
subacute when signs and symptoms have been present for 1 to 7
days. Most cases of meningitis are acute, but some are chronic due
to the invasion of pathogens from a neighboring infected site (10).
The common infectious agents of acute meningitis are viruses
(mainly enteroviruses and, to a lesser degree, HIV, herpes simplex viruses (HSV), and mumps virus), bacteria (Streptococcus
pneumoniae, Neisseria meningitidis, Streptococcus agalactiae (group B
streptococci), Haemophilus influenzae, and Listeria monocytogenes).
Less common causes of acute meningitis include parasites (Naegleria fowleri, Strongyloides stercoralis, and Acanthamoeba cantonensis).
Subacute or chronic meningitis is characterized by delayed symptoms over weeks to months or even years. These patients may
also have some acute meningitis symptoms, but the onset is more
gradual, with lower fever and possibly associated lethargy and
disability. This type of meningitis may be caused by Mycobacteria
spp., spirochetes, Cryptococcus neoformans, Candida spp., and Coccidioides spp. (1,3).
Bacterial meningitis
Bacterial meningitis is a major cause of morbidity and mortality, especially among children less than 5 years of age. The rapid
progression of symptoms and potentially devastating effect of the
disease necessitate early recognition and immediate treatment.
Shock, coagulation disorders, endocarditis, pyogenic arthritis,
and prolonged fever are the most common bacterial meningitis
complications (2). Despite many new antibacterial agents, bacterial
meningitis fatality rates remain high, with reported rates between
44
Drug hypersensitivity
antimicrobials
Systemic diseases
Neoplastic diseases
Chemical agents
a
NSAID
4,5
SLE
Metastatic carcinoma
Anaesthetics
2% and 30%. Permanent sequelae, such as epilepsy, mental retardation, or sensorineural deafness, are observed in 10% to 20% of
those who survive (11,12).
In general, all human microbes can cause meningitis, but only
a few species account for most cases of bacterial meningitis. S.
agalactiae and Escherichia coli commonly infect neonates up to 3
months of age and are acquired during the passage of the baby
through a colonized vaginal canal. H. influenzae infects unvaccinated children between the age of 3 to 6 months and 6 years.
N. meningitidis infects children and young adults and is the only
organism that causes meningitis epidemics. S. pneumoniae occasionally infects children and increases in incidence with age. L.
monocytogenes appears to be foodborne (dairy products, processed
meat, and uncooked vegetables) and infects people with defective
immunity or those receiving certain therapies (1-3). Some studies
report a dramatic drop in developed countries as a result of the
introduction of vaccines against common bacterial agents, such
as S. pneumoniae, H. influenzae type b, and N. meningitidis (2,11).
Data for community-acquired acute bacterial meningitis suggest
that almost 50% of cases are due to S. pneumoniae, 25% to N. meningitidis, 13% to group B streptococci, 8% to L. monocytogenes, and
7% to H. influenzae. In contrast, nosocomial meningitis is associated with enteric gram-negative bacilli in up to 33% of cases. The
most common gram-negative bacterial agents in adults are E. coli
and Klebsiella/Enterobacter spp. Mortality rates of bacterial meningitis in adults remain at approximately 20% but rise to at least 40%
for those older than age 60 (13). In neonates, S. agalactiae and E.
coli are the most common agents of meningitis in North America
(11), Australasia (14), and Europe (15). The morbidity rate of
neonatal meningitis is up to 56%; if not treated, the mortality can
approach 100% (16). In rare situations, other bacterial pathogens
can cause acute meningitis, including coagulase-negative staphylococci, Burkholderia pseudomallei, Pseudomonas aeruginosa, miscellaneous gram-negative bacilli, Staphylococcus aureus, viridans
streptococci, and anaerobic bacteria. Mixed bacterial infections
might occur as complications of neurosurgical procedures (e.g.,
spinal puncture) and low immunity status. Meningitis caused by
group A streptococci is uncommon but occasionally occurs after
acute otitis media. In approximately 10% of patients with acute
bacterial meningitis, the bacterial cause cannot be defined but is
diagnosed on the basis of other differential laboratory findings (3).
Mycobacterium tuberculosis, Treponema pallidum and Borrelia burg
dorferi are considered to be the most common causes of chronic
Fungal meningitis is rare but poses a significant challenge, spanning a wide array of hosts, including immunocompetent and
immunosuppressed individuals, patients undergoing neurosurgical
procedures, and those with implantable CNS devices. C. neoformansandAspergillusspp. are the most common fungal pathogens
(51). C. neoformansinfection is acquired by the inhalation route
and can be asymptomatic and limited to the lungs in immunocompetent hosts. Upon immunosuppression, hematogenous
dissemination to the meninges may occur, which can end with a
fatal outcome in the absence of prompt management. Lympho
proliferative malignancies, steroid therapy, diabetes mellitus, and
AIDS are the most common predisposing factors for cryptococcal meningitis (51). C. neoformans is the most common cause of
meningitis in immunosuppressed and AIDS patients; the mortality rate in that population ranges from 10 to 30% and from 13 to
44% in developed and developing countries, respectively (52,53).
In one retrospective study performed in India, the prevalence of
C. neoformans among HIV patients was 14.3% (53). Candida spp.
cause acute meningitis indistinguishable from bacterial meningitis
Routinely, CSF is collected into three sterile tubes from the same
puncture after considering the proper intracranial pressure. The
first tube is used for chemical and immunological testing due to
the potential for cell contamination during collection. To avoid
surface flora contamination, the second tube is selected for microbiological and molecular testing. The last volume collected best
represents the actual cellular composition of the CSF and is ideal
for cytological testing. In cases where a low volume of CSF is
collected, the sample is triaged for microbiology, cytology, and
chemistry, respectively, to optimize findings. After collection, the
sample is assessed for normal color, clarity, and viscosity and then
sent for further laboratory examination (65).
Cytology
45
Table 2. Recent surveys and outbreaks of acute meningitis in selected countries worldwide
Age group
Predominant pathogensa
Study interval
Diagnostic methodc
Reference
India
Allb
2009-2010
Culture
19
Japan
Neonates
2008-2010
Culture
20
Japan
Adult
2004-2014
PCR, culture
21
China
All
2006-2009
Agglutination, culture
22
China
Pediatric
Enteroviruses, adenoviruses
2006-2012
PCR, culture
23
China
Pediatric
Outbreak
2008, 2012
PCR, culture,
genotyping
24
Australia
All
2007-2013
PCR, culture,
genotyping
25
Jordan
Pediatric
Enteroviruses
1999
Culture, IFA
26
Palestine
Adults
1978-2012
Culture, serology
27
Kuwait
Pediatric
2006-2009
PCR, hybridization
28
All
Outbreak,
2009-2013
PCR, culture,
genotyping
29,30-32
Turkey
Children
2005-2006
PCR, culture
38
Denmark
All
S. pneumoniae, N. meningitidis,
streptococcus groups A, B, G
1998-2010
Agglutination,
culture
39
UK
Neonates
2010-2011
40
Iceland
Children
N. meningitidis, H. influenzae
S. pneumoniae, S. agalactiae
1975-2010
41
Spain
Adults,
Elderly
1982-2010
42
Brazil, Panama
All
2005, 2008
PCR, culture,
genotyping
43,44
Brazil
All
N. meningitidis, S. pneumoniae
H. influenzae
2004-2006
2000-2010
Gram stain
PCR, agglutination
45,46
USA
All
S. pneumoniae, N. meningitidis
1998-2007
Culture
11
USA
All
5 yr
PCR, culture,
genotyping
47
Malawi
Neonates
2002-2008
12
Burkina Faso
Children
2004-2012
Gram stain,
PCR, culture
48
Niger
All
2002-2010
PCR, culture,
agglutination
49
South Africa
Pediatric
2010-2011
PCR, culture,
genotyping
18
Kenya
Pediatric
2014
50
Country
Asia
Middle East
Europe
Americas
Africa
Pathogens are listed in the order of highest frequency to lowest frequency. VZV, varicella-zoster virus.
All includes pediatric patients, adults, and the elderly.
IFA, immunofluorescence assay.
b
c
46
Numerous chemical constituents in the CSF sample are evaluated, but few give useful diagnostic data for meningitis etiology. Since result values differ in response to the different types
of microorganisms involved, assays such as glucose, lactate, and
various proteins assays can provide diagnostic information (Table
4) and help classify the type of meningitis, but results from cytology and chemistry laboratories cannot conclusively determine
whether the infection is bacterial, viral, fungal, or parasitic due to
similarity of results that may be obtained in response to infections
Meningitis etiology
Risk factora
Diagnostic methodb
50 yr/male
Rhodotorula glutinis
AIDS
Outcome
Reference
Cured
54
34 yr/male
C. neoformans
AIDS
Culture
Cured
55
42 yr/male
C. neoformans
HIV-induced IRIS
Relapsed
56
19 mo/male
A. cantonensis
Poor hygiene
Microscopy
Cured
68
64 yr/male
Abiotrophia defectiva
Neurosurgical
procedures
Culture, genotyping
Cured
57
17 mo/male
M. tuberculosis
Disseminated
tuberculosis
PCR
Cured
59
18 mo/male
M. tuberculosis
Disseminated
tuberculosis
CT scan
Cured
52 yr/female
Pantoea calida
Post surgery
Culture, genotyping
Cured
60
36 yr/male
Salmonella enterica
serovar Virchow
Salmonella Virchow
carrier
Culture
Cured
61
21 yr/female
Mycobacterium chelonae
Culture, RFLP
Cured
62
6 yr/male
N. fowleri
Contaminated water
reservoir
Microscopy
Cured
63
8 mo/male
Methicillin-resistant
S. aureus (MRSA)
MRSA sepsis
Culture
Cured
64
Complication
Reversible blindness
Agglutination
Permanent
neurological sequelae
Communicating
hydrocephalus
47
Immunoassays are based on the principle of antigen-antibody reaction for identification of microbial agents. Microbial structures,
such as capsules, can be targeted as an antigen and then detected
by a reagent antibody. Rapid antigen detection from CSF has been
largely accomplished by the principles of latex agglutination, coagglutination, immunoassay, and counter-immunoelectrophoresis.
Immunoassays represent a screening tool for primary diagnosis,
along with other screens for microbial detection and cell counting.
Currently, immunologic tests are applicable for the detection of
several types of bacteria and fungi that cause meningitis, including S. pneumoniae, S. agalactiae, H. influenzae, N. meningitidis, Coccidioides immitis, M. tuberculosis, and C. neoformans. Additionally,
certain kits are used to detect either antibodies or antigens that
are specific for some viruses (10,65). The latex slide agglutination
test for C. neoformans antigen shows moderate to high sensitivity (60% to 99%) and specificity (80% to 99%). In addition, the
antigen titer serves as a good prognostic indicator (65). However,
CSF serology for detection of bacterial antigens is not widely used
because it has lower sensitivity and specificity than Gram stain and
culture (3,10,65).
Molecular methods and applications
Molecular assays have become widely applied in the microbiology field as diagnostic and research tools. Molecular techniques
are used for confirmatory diagnosis and have been gradually
introduced for routine primary diagnosis of viral meningitis (10).
Nucleic acid assays, mainly PCR and its variants, have been used
in diagnosis involving direct detection of microorganisms in CSF
specimens, confirmation of bacteria and viruses grown in culture
media and cell lines, genotyping of viruses beyond identification
for molecular epidemiology and phylogenetic purposes, and identification of antimicrobial resistance for certain bacteria.
Molecular methods shorten diagnosis time (up to 4 hours) and
have increased specificity and sensitivity of diagnosis. Additionally, they solve the discrepancy problems in suspected patients who
show culture-negative results. These combined characteristics provide advantages for PCR over any other laboratory test (10,23).
Reverse transcription (RT)-PCR targeting the 5' non-translated
region (NTR) of the enteroviral genome, which is the most conserved genomic region, is essential for enteroviral-meningitis diagnosis and delivers results in as little as 5 hours, thereby shortening
inpatient hospital stays and minimizing the unnecessary use of
empirical antimicrobial agents. In comparison with cell line culture, RT-PCR sensitivity and specificity in CSF are 85 to 100%
and 90 to 100%, respectively. PCR for HSV-2 DNA is usually
positive in the CSF of patients with initial episodes of meningitis. PCR is also is positive in approximately 80% of patients with
benign recurrent meningitis caused by lymphocytic choriomeningitis virus (2,18).
A systematic review and meta-analysis study was performed to
evaluate the accuracy of broad-range 16S rRNA PCR in the diagnosis of bacterial meningitis. The study judged the benefit of PCR
for diagnosis in emergency departments (68). Fourteen articles
were analyzed, in which 488/2,780 CSF samples were proven to
WBCs (cells/l)
Normal
Bacterial meningitis
Tuberculosis-meningitis
0-5
>1,000
100-500
Glucose (mg/dl)
Protein (mg/dl)
45-100
15-50
<40
>100
Lymphocytes, monocytes
40
>50
Normal
50-150
None
Viral meningitis
5-500
Lymphocytes
Fungal meningitis
5-500
40
>100
Parasitic meningitis
2-200
Eosinophils, neutrophils
40
>50
48
Therapeutic Management
The ideal antibiotic for CNS infection would be inexpensive and
would cover a broad range of gram-positive and -negative bacteria
(13). If the infecting organism is observed on examination of the
Gram-stained smear of the CSF sediment collected from a patient
with suspected bacterial meningitis, specific therapy is initiated;
otherwise, empirical antimicrobial therapy should be initiated.
Prompt treatment of bacterial meningitis usually results in rapid
recovery of neurologic function.
Bacterial meningitis is treated using various antibacterial families
such as beta-lactams, cephalosporins, aminoglycosides, fluoroquinolones, and other drugs, like trimethoprim-sulfamethoxazole
and vancomycin; the type of antibiotic, its dose and duration, and
whether to combine it with other antibiotics are all decided by
the physician according to the causative agent, patients age, and
other clinical considerations.
Effective vaccines are now available for many subtypes of H. influenzae type b, meningococcal serogroups (A, C, Y, and W-135),
S. pneumoniae, M. tuberculosis, and S. agalactiae (2). Adherence to
recommended vaccination schedules substantially reduces meningitis from each of those organisms. Previous studies indicated that
five bacteria, namely, H. influenzae, N. meningitidis, S. pneumoniae,
L. monocytogenes, and S. agalactiae, accounted for almost 80% of
cases of meningitis. However, upon the introduction of conjugate
vaccines, substantial reduction in the prevalence of cases due to
these five pathogens was achieved (59,69). Another study reported
a 31% decline in the incidence of bacterial meningitis during the
surveillance periods 1998-1999 and 2006-2007 (11).
Most viral-meningitis cases are self-limited, but some cause
chronic or recurrent illness. Treatment of acute viral meningitis
is directed at relief of symptoms, supportive care, and prevention and management of complications. Full recovery from viral
meningitis usually occurs within 1 to 2 weeks of onset, although
some patients describe persistence of fatigue, lightheadedness,
Conclusion
Infectious meningitis is a large public health concern. Continuous diagnosis improvement is necessary to minimize disease mortality and life-threatening complications. Continued updates to
describe prevalence and expanded reporting of outbreaks will help
to evaluate vaccination outcomes and impact. Viral genotyping in
outbreaks provides a clearer picture for virus epidemiology and
geographical distribution and helps predict the emergence of new
strains by phylogenetic studies.
References
1. Matthew, P.F. 2007. The nervous system, p. 873-881. In A.K. Abbas,
V. Kumar, N. Fausto, and R. Mitchell (ed.), Robbins basic pathology.
Saunders Elsevier, Philadelphia, PA.
2. Morton, N.S. and A. Nath. 2012. Meningitis: bacterial, viral, and
other, p. 2355-2370. In Lee Goldman (ed.), Goldmans Cecil medicine. Saunders Elsevier, Philadelphia, PA.
3. Tunkel, A.R. 2015. Central nervous system infections, p. 1091-1093.
In R.D. John, E. Bennett, and M.J. Blaser (ed.), Mandell, Douglas
and Bennetts principles and practice of infectious diseases. Saunders
Elsevier, Philadelphia, PA.
4. Davison, S.P. and M.S. Marion. 1998. Sensorineural hearing loss
caused by NSAID-induced aseptic meningitis. Ear Nose Throat J.
77:820-821.
5. Lockwood, J.R. and D. Carr. 2014. Drug-induced aseptic meningitis
secondary to trimethoprim/sulfamethoxazole: a headache to be aware
of. CJEM 16:421-424.
6. Al-Shareef, A. and S.M. Atar. 2014. Central nervous system manifestation in patients with SLE: A 12-year retrospective chart review at a
tertiary center. Kuwait Med. J. 46:14-20.
7. Silvani, A. et al. 2013. Neoplastic meningitis from solid tumors: a
prospective clinical study in lombardia and a literature review on
therapeutic approaches. J. Drug Deliv. 2013:147325.
8. Akhtaruzzaman, A. et al. 2014. Outbreak of bacterial meningitis after
49
50
56. Nunnari, G. et al. 2013. Cryptococcal meningitis in an HIV-1infected person: relapses or IRIS? Case report and review of the literature. Eur. Rev. Med. Pharmacol. Sci. 17:1555-1559.
66. Walker, T.J. et al. 2009. Comparative evaluation of the Iris iQ200
body fluid module with manual hemacytometer count. Am. J. Clin.
Pathol. 131:333-338.
67. Corless, C.E. et al. 2001. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in
suspected cases of meningitis and septicemia using real-time PCR. J.
Clin. Microbiol. 39:1553-1558.
51